切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (03) : 245 -252. doi: 10.3877/cma.j.issn.1673-5250.2019.03.003

所属专题: 文献

论著

前白蛋白在孕妇血清及胎盘组织的表达与妊娠期高血压疾病严重程度的关系
金艳荣1, 马红梅1,(), 张震宇2, 刘崇东2, 罗玫1, 刘彤3   
  1. 1. 首都医科大学附属北京潞河医院妇产科 101149
    2. 首都医科大学附属北京朝阳医院妇产科 100020
    3. 首都医科大学附属北京潞河医院病理科 101149
  • 收稿日期:2018-11-04 修回日期:2019-05-15 出版日期:2019-06-01
  • 通信作者: 马红梅

Expression of prealbumin in maternal serum and placenta tissue of pregnant women and its relation with severity of hypertensive disorder complicating pregnancy

Yanrong Jin1, Hongmei Ma1,(), Zhenyu Zhang2, Chongdong Liu2, Mei Luo1, Tong Liu3   

  1. 1. Department of Obstetrics and Gynecology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China
    2. Department of Obstetrics and Gynecology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China
    3. Department of Pathology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China
  • Received:2018-11-04 Revised:2019-05-15 Published:2019-06-01
  • Corresponding author: Hongmei Ma
  • About author:
    Corresponding author: Ma Hongmei, Email:
  • Supported by:
    International Science & Technology Cooperation Program of China(2015DFR31070)
引用本文:

金艳荣, 马红梅, 张震宇, 刘崇东, 罗玫, 刘彤. 前白蛋白在孕妇血清及胎盘组织的表达与妊娠期高血压疾病严重程度的关系[J]. 中华妇幼临床医学杂志(电子版), 2019, 15(03): 245-252.

Yanrong Jin, Hongmei Ma, Zhenyu Zhang, Chongdong Liu, Mei Luo, Tong Liu. Expression of prealbumin in maternal serum and placenta tissue of pregnant women and its relation with severity of hypertensive disorder complicating pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(03): 245-252.

目的

探讨在妊娠期高血压疾病、子痫前期(PE)、PE合并胎儿宫内生长受限(FGR)的孕妇血清及胎盘组织中,前白蛋白(PBA)表达及其临床意义。

方法

选择2014年1月至2016年1月,在首都医科大学附属北京潞河医院进行常规产前检查,并采取剖宫产术分娩的98例罹患不同程度妊娠期高血压疾病的单胎妊娠孕妇为研究对象。其中,被诊断为妊娠期高血压疾病者为31例、单纯PE者为33例、PE合并FGR者为34例,将其分别纳入妊娠期高血压疾病组、单纯PE组、PE合并FGR组。单纯PE组与PE合并FGR组的67例孕妇中,早发型PE为30例,晚发型PE为37例。选择同期于收集上述病例的同一家医院进行常规产前检查,并采取剖宫产术分娩的36例正常足月单胎妊娠孕妇作为研究对照,纳入对照组。分别采用酶联免疫吸附试验法与免疫组化法,对分娩前4组孕妇的血清及胎盘组织PBA表达进行检测。4组孕妇血清PBA比较,采用单因素方差分析,进一步两两比较,采用最小显著性差异(LSD)法。4组孕妇胎盘组织PBA表达呈阴性、弱阳性、中度阳性、较强阳性、强阳性率比较,采用Kruskal-Wallis H秩和检验,进一步两两比较,采用Mann-Whitney U检验,并采用Bonferroni法调整检验水准(α′=0.05/6=0.008)。本研究遵循的程序符合首都医科大学附属北京潞河医院人体试验委员会制定的标准,经过该伦理委员会批准(批准文号:2018LH-KS-025),并与所有受试者签署临床研究知情同意书。

结果

①4组孕妇年龄、孕次、产次、孕前人体质量指数(BMI)等一般临床资料比较,差异均无统计学意义(P>0.05)。②4组孕妇平均动脉压、24 h尿蛋白定量、分娩孕龄、新生儿出生体重、血清PBA比较,差异均有统计学意义(F=233.773、222.081、113.597、214.420、90.147,P<0.001)。对4组孕妇血清PBA进一步进行两两比较的结果显示,妊娠期高血压疾病组、单纯PE组、PE合并FGR组孕妇血清PBA,均显著低于对照组,单纯PE组、PE合并FGR组孕妇血清PBA,均显著低于妊娠期高血压疾病组,PE合并FGR组孕妇血清PBA,显著低于单纯PE组,并且差异均有统计学意义(P<0.05)。③PBA表达于胎盘绒毛滋养细胞细胞质,为粗大棕褐色颗粒。对照组孕妇胎盘组织中,PBA呈较强阳性和(或)强阳性表达;单纯PE组及PE合并FGR组孕妇胎盘组织中,PBA呈阴性或弱阳性表达;妊娠期高血压疾病组,则呈中度阳性表达。④4组孕妇胎盘组织PBA表达呈阴性、弱阳性、中度阳性、较强阳性、强阳性率总体比较,差异有统计学意义(χ2=39.405,P=0.013)。进一步进行两两比较的结果显示,与对照组相比,单纯PE组、PE合并FGR组孕妇胎盘组织PBA减低,并且差有统计学意义(Z=3.416、4.846,P<0.001);与妊娠期高血压疾病组相比,PE合并FGR组孕妇胎盘组织PBA减低,并且差异有统计学意义(Z=2.829,P=0.004)。⑤早发型PE孕妇血清及胎盘组织PBA,均较晚发型PE低,并且差异均有统计学意义(t=3.160、P=0.002,χ2=8.201、P<0.001)。

结论

PBA在妊娠期高血压疾病、PE、PE合并FGR孕妇血清及胎盘组织中,均呈低表达,在早发型PE孕妇中尤其明显,并且PBA随着妊娠期高血压疾病严重程度增加,而降低。

Objective

To investigate the expressions of prealbumin (PBA) in maternal serum and placenta tissue of pregnant women with hypertensive disorder complicating pregnancy, preeclampsia (PE) and PE with fetal growth restriction (FGR) and its clinical significance.

Methods

A total of 98 cases of singleton pregnancy women with different degrees of hypertensive disorder complicating pregnancy who had routine prenatal examination and delivered by cesarean section in Beijing Luhe Hospital, Capital Medical University from January 2014 to January 2016 were selected as research subjects. Among them, 31 pregnant women with hypertensive disorder complicating pregnancy, 33 cases with PE, and 34 cases with PE and FGR were divided into hypertensive disorder complicating pregnancy group, simple PE group and PE with FGR group, respectively. There were 30 cases of early-onset PE and 37 cases of late-onset PE among 67 pregnant women in simple PE group and PE with FGR group. Another 36 cases of normal full-term singleton pregnancy women who had routine prenatal examination and delivered by cesarean section in the same hospital during the same period were included into control group. Enzyme linked immunosorbent assay and immunohistochemical method were applied to detect the serum PBA levels and the expressions of PBA in placenta tissues of pregnant women before delivery. The serum PBA levels of 4 groups were compared by one-way ANOVA method, and further pairwise comparison was conducted by least-significant difference (LSD) method. Rates of negative, weakly positive, moderately positive, less strongly positive and strongly positive PBA expressions in placenta tissues of pregnant women in 4 groups were compared by Kruskal-Wallis H rank sum test, and Mann-Whitney U test was used for further pairwise comparison by adjusting size of test with Bonferroni method (α′=0.05/6=0.008). The procedures followed in this study were in accordance with the standards established by the Committee of Investigation in Human Beings Beijing Luhe Hospital, Capital Medical University, and this study was approved by the committee (Approval No. 2018LH-KS-025). All the subjects signed the informed consents for clinical trials.

Results

①There were no statistical differences among 4 groups in the general clinical data, such as age, gravidity, parity, and body mass index (BMI) before pregnancy and so on (P>0.05). ②There were statistical differences among 4 groups in the mean arterial pressure, 24 h urine protein quantitation, gestational age, neonatal birth weight and serum PBA level (F=233.773, 222.081, 113.597, 214.420, 90.147; P<0.001). The results of further pairwise comparison of serum PBA levels among 4 groups showed that the serum PBA levels in hypertensive disorder complicating pregnancy group, simple PE group and PE with FGR group were significantly lower than that in the control group, serum PBA levels in simple PE group and PE with FGR group were significantly lower than that in hypertensive disorder complicating pregnancy group, serum PBA level in PE with FGR group was significantly lower than that in simple PE group, and all the differences were statistically significant (P<0.05). ③PBA was expressed in cytoplasm of placental villus trophoblast cells and represented as coarse brown particles. In maternal placental tissues of pregnant women in control group, PBA was less strongly positively and/ or strongly positively expressed in maternal placental tissues of pregnant women in simple PE group and PE with FGR group, PBA was negatively or weakly positively expressed; and PBA was moderately positively expressed in maternal placental tissues of pregnant women in hypertensive disorder complicating pregnancy group. ④There were statistical differences among 4 groups in the rates of negative, weakly positive, moderately positive, less strongly positive and strongly positive expression of PBA in maternal placental tissues (χ2=39.405, P=0.013). The results of further pairwise comparison showed that PBA expression in maternal placental tissues of pregnant women in simple PE group and PE with FGR group both were lower than that in the control group, and both the differences were statistically significant (Z=3.416, 4.846; P<0.001). Compared with hypertensive disorder complicating pregnancy group, PBA expression in maternal placental tissues of pregnant women in PE with FGR group decreased, and the difference was statistically significant (Z=2.829, P=0.004). ⑤Serum PBA level and PBA expression in maternal placental tissues of pregnant women with early-onset PE were lower than those with late-onset PE, and the differences were statistically significant (t=3.160, P=0.002; χ2=8.201, P<0.001).

Conclusions

PBA is lowly expressed in serum and placental tissues of pregnant women with hypertensive disorder complicating pregnancy, PE, and PE combined with FGR, especially in pregnant women with early-onset PE. And the expression level of PBA decreases as the severity of hypertensive disorder complicating pregnancy increases.

表1 4组孕妇一般临床资料比较
表2 4组孕妇平均动脉压、24 h尿蛋白定量、分娩孕龄、血清前白蛋白及新生儿出生体重比较(±s)
图1 采用免疫组织化学方法检测4组孕妇胎盘组织前白蛋白表达[图1A、1B:对照组孕妇胎盘组织PBA呈强阳性表达,表现为胎盘绒毛滋养细胞的细胞质含有粗大的明显棕褐色颗粒(图1A:×200 倍,图1B:×400 倍);图1C、1D:妊娠期高血压疾病组孕妇胎盘组织PBA呈中度阳性表达,表现为胎盘绒毛滋养细胞的细胞质含有较粗大的浅棕褐色颗粒(图1C:×200 倍,图2D:×400 倍);图1E、1F:单纯PE组孕妇胎盘组织PBA呈弱阳性或阴性表达,表现为胎盘绒毛滋养细胞的细胞质含有细小的褐色颗粒(图1E:×200 倍,图1F:×400 倍);图1G、1H:PE合并FGR组孕妇胎盘组织PBA呈弱阳性或阴性表达,表现为胎盘绒毛滋养细胞的细胞质含有细小的浅褐色颗粒(图1G:×200 倍,图1H:×400 倍)(PV6000二步法染色)
表3 4组孕妇胎盘组织前白蛋白表达比较[例数(%)]
表4 早发型与晚发型子痫前期孕妇血清及胎盘组织前白蛋白表达比较
[1]
张凯斐,吕晴晴,孙宁,等. 妊娠期高血压疾病所致早产孕妇的母婴围生结局分析[J/CD]. 中华妇幼临床医学杂志(电子版), 2018, 14(5): 558-565.
[2]
曹泽毅. 中华妇产科学(上册)[M]. 3版. 北京:人民卫生出版社,2014: 154-170.
[3]
李冠琳,杨慧霞. 子痫前期的发病机制及亚型分类[J]. 中华围产医学杂志,2017, 20(12): 899-903.
[4]
胡静,陈沂,高劲松. 早孕期联合筛查预测子痫前期[J]. 中华围产医学杂志,2017, 20(1): 2-6.
[5]
董旭东,朱宝生,焦存仙,等. 妊娠相关血浆蛋白-A预测妊娠期高血压疾病的价值[J/CD]. 中华妇幼临床医学杂志(电子版), 2007, 3(5): 249-251.
[6]
Landers KA, Mortimer RH, Richard K. Transthyretin and the human placenta[J]. Placenta, 2013, 34(7): 513-517.
[7]
Landers KA, McKinnon BD, Li HK, et al. Carrier-mediated thyroid hormone transport into placenta by placental transthyretin[J]. J Clin Endocrinol Metab, 2009, 94(7): 2610-2616.
[8]
钟琳琳,唐卉,陈悦. 重度先兆子痫孕妇发病孕龄与母婴预后的关系[J/CD]. 中华妇幼临床医学杂志(电子版), 2014, 10(4): 521-524.
[9]
刘崇东,鲁琦,张震宇,等. 用蛋白质组学方法分析先兆子痫孕妇血清差异蛋白表达和急性反应蛋白[J]. 首都医科大学学报,2012, 33(1): 20-25.
[10]
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015, 50(10): 721-728.
[11]
麻秀丽,鲁琦,张震宇. 妊娠期孕妇血清TTR水平变化及其用于诊断子痫前期的价值[J]. 现代妇产科进展,2016, 25(7): 523-526.
[12]
Patel J, Landers KA, Li H, et al. Ontogenic changes in placental transthyretin[J]. Placenta, 2011, 32(11): 817-822.
[13]
Gertz MA, Benson MD, Dyck PJ, et al. Diagnosis, prognosis, and therapy of transthyretin amyloidosis[J]. J Am Coll Cardiol, 2015, 66(21): 2451-2466.
[14]
Wang QS, Liu CD, Zhang ZY. Transthyretin and normal human pregnancy: mini review[J]. Crit Rev Eukaryot Gene Expr, 2016, 26(3): 273-277.
[15]
Landers KA, Li H, Subramaniam VN, et al. Transthyretin-thyroid hormone internalization by trophoblasts[J]. Placenta, 2013, 34(8): 716-718
[16]
McKinnon B, Li H, Richard K, et al. Synthesis of thyroid hormone binding proteins transthyretin and albumin by human trophoblast[J]. J Clin Endocrinol Metab, 2005, 90(12): 6714-6720.
[17]
Mortimer RH, Landers KA, Balakrishnan B, et al. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta[J]. Placenta, 2012, 33(4): 252-256.
[18]
Saha S, Chakraborty S, Bhattacharya A, et al. MicroRNA regulation of transthyretin in trophoblast differentiation and intra-uterine growth restriction[J]. Sci Rep, 2017, 7(1): 16548.
[19]
Landers KA, McKinnon BD, Li H, et al. Carrier-mediated thyroid hormone transport into placenta by placental transthyretin[J]. J Clin Endocrinol Metab, 2009, 94(7): 2610-2616.
[20]
Kalkunte SS, Neubeck S, Norris WE, et al. Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model[J]. Am J Pathol, 2013, 183(5): 1425-1436.
[21]
Zhu L, Chen YX, Liu CD. Transthyretin as a novel candidate biomarker for preeclampsia[J]. Exp Ther Med, 2014, 7(5): 1332-1336.
[22]
Roberts JM. Pathophysiology of ischemic placental disease[J]. Semin Perinatol, 2014, 38(3): 139-145.
[23]
杨林东,张承,卞雯雯,等. 预测子痫前期的生物学标志物研究进展[J/CD]. 中华妇幼临床医学杂志(电子版),2015,11(2): 269-273.
[24]
Chen YX, Zhang ZY. Does transthyretin function as one of contributors for preeclampsia?[J]. Med Hypotheses, 2011, 76(1): 8-10.
[25]
Gong LY, Zhu L, Wang SZ, et al. Transthyretin regulates the migration and invasion of JEG-3 cells[J]. Oncol Lett, 2017, 13(3): 1242-1246.
[26]
Kalkunte SS, Neubeck S, Norris WE, et al. Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model[J]. Am J Pathol, 2013, 183(5): 1425-1436.
[27]
Stanek J. Histological features of shallow placental implantation unify early-onset and late-onset preeclampsia[J]. Pediatr Dev Pathol, 2019, 22(2): 112-122.
[28]
Fruscalzo A, Schmitz R, Klockenbusch W, et al. Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome[J]. Histochem Cell Biol, 2012, 138(6): 925-932.
[1] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[2] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[3] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[6] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[7] 陈樱, 陈艳莉. 高龄孕妇心率变异性原因及围产结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 295-301.
[8] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[9] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[10] 邬龙海, 黄淼, 龚云辉, 喻云倩. 血清趋化因子在妊娠期糖尿病孕妇中的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 357-362.
[11] 马铭秀, 徐锋, 谢铠岭, 郭亚明, 卢潼辉, 戴朝六. 术前碱性磷酸酶-前白蛋白比值对肝细胞癌切除术预后的评估价值[J]. 中华普通外科学文献(电子版), 2023, 17(02): 99-103.
[12] 韦先梅, 韩毓, 蒋英彩. 敲减circSERPINE2通过靶向调控miR-34a-5p表达抑制滋养层细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 193-201.
[13] 刘雪云, 范颖, 姚爱军, 张胜苗, 吕亚妮, 张冰清, 张晓宇, 刘恒. 基于微信小程序的个体化、全程护理干预对孕妇孕期体重及分娩结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 455-460.
[14] 郑晓芳, 魏宋荃, 黄真轩, 吴文诗, 李桂民, 张红霞, 江庆萍, 陈敦金, 余琳. 子痫前期合并胎儿生长受限的妊娠结局及胎盘病理改变的研究[J]. 中华产科急救电子杂志, 2023, 12(02): 85-92.
[15] 王晓怡, 洪凡, 陈晴晴, 孙雯. 新型冠状病毒感染疫情高发状态下封闭封控管理区孕产妇的管理方案研究[J]. 中华产科急救电子杂志, 2023, 12(02): 109-112.
阅读次数
全文


摘要